New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03469115

Enrollment

100

Registered

2018-03-19

Start date

2018-03-31

Completion date

2019-09-30

Last updated

2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

The purpose of this study is to find out if there is a connection between a higher level of peptide alpha defensin in blood serum with the metabolic profile of adolescents aged 13-17.

Interventions

DIAGNOSTIC_TESTSerum blood

Serum blood test for laboratory analysis to determine level of alpha defensin

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

NONE

Intervention model description

Adolescents aged 13-17 will be divided into two groups according to BMI (body mass index)

Eligibility

Sex/Gender

ALL

Age

13 Years to 17 Years

Healthy volunteers

Yes

Inclusion criteria

* Youths with metabolic syndrome (BMI above 95%) * Youths with BMI below 3%

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Alpha defensin level	2 hours	Alpha defensin level above 12ng/microliter

Countries

Israel

Contacts

Primary ContactEias Kassem, MD

eiask@hy.health.gov.il972-50-6246882

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026